Quantcast

Latest Esophageal cancer Stories

2014-06-09 12:30:34

Quality-of-Life Survey Scores on Medications and Presence of Esophagitis Appear to Be Best Correlated Predictors of Success SAN MATEO, Calif., June 9, 2014 /PRNewswire/ -- EndoGastric Solutions® (EGS), a leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced publication of US registry data on patient factors predictive of positive outcomes following transoral incisionless fundoplication (TIF). The study demonstrates that patients with an...

2014-06-09 12:29:50

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Japanese Gastrointestinal Devices Markethttp://www.reportbuyer.com/pharma_healthcare/diagnostics/japanese_gastrointestinal_devices_market.html In 2011, the Japanese market for gastrointestinal endoscopic devices was valued at over $801 million. The Japanese gastrointestinal (GI) endoscopic device market includes GI endoscopes, capsule endoscopes, stenting devices, dilation devices,...

2014-05-31 08:21:15

New DecisionDx-EC multi-analyte test data presented at ASCO 2014 CHICAGO, May 31, 2014 /PRNewswire/ -- Castle Biosciences Inc. today announced study results from its proprietary multi-analyte test DecisionDx-EC, which is designed to determine which patients with esophageal cancer are likely to respond or not respond to standard pre-surgical chemoradiation therapy. The results were reviewed in a poster presentation at the 50(th) Annual Meeting of the American Society of Clinical...

2014-05-20 08:26:56

NORWALK, Conn., May 20, 2014 /PRNewswire/ -- The Emmy Award-winning TV program The Doctors recently featured the case of "Jenny," a 29-year-old with severe gastroesophageal reflux disease (GERD). Jenny suffered for three years before she turned to University of California Irvine's Dr. Kenneth Chang for a solution in the form of Stretta(®) therapy. http://photos.prnewswire.com/prnvar/20130211/NY56794 Jenny had chronic GERD that was uncontrolled with medications and suffered from...

2014-05-19 23:05:05

Abington Memorial Hospital is pleased to announce Dr. Colleen Gaughan has joined Abington Memorial Hospital as a thoracic surgeon. Dr. Gaughan specializes in the treatment of lung and esophageal cancer, tumors of the mediastinum, chest wall and trachea, as well as all benign conditions of the chest, lungs, esophagus, chest wall and mediastinum. ABINGTON, PA (PRWEB) May 19, 2014 Abington Memorial Hospital is pleased to announce Dr. Colleen Gaughan has joined Abington Memorial Hospital as a...

2014-05-14 23:02:50

Jonathan Aviv MD, Clinical Director of the Ear, Nose, Throat, Allergy and Audiology Practice’s Voice and Swallowing Center, appears on the Dr. Oz TV Show discussing his new Acid Reflux book ‘Killing Me Softly From Inside’ Tarrytown, N.Y. (PRWEB) May 14, 2014 Voice and swallowing specialist Dr. Jonathan Aviv, MD, inventor and developer of the endoscopic air-pulse laryngeal sensory testing technology known as FEESST (Flexible Endoscopic Evaluation of Swallowing with Sensory Testing),...

2014-05-14 16:29:17

DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests -- one focused on melanoma and the other on esophageal adenocarcinoma -- will be presented at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 3,...

2014-05-06 08:34:50

Enables physicians to pursue more effective treatment plans for patients who are chemoradiation resistant CHICAGO, May 6, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced that data from two clinical validation studies of its DecisionDx-EC multi-biomarker test were reviewed in an oral presentation at the Digestive Disease Week (DDW) Annual Meeting. The data show that the test accurately predicts response to pre-surgical chemoradiation therapy (CTRT) in patients with esophageal...

2014-04-22 08:33:00

BETHESDA, Md., April 22, 2014 /PRNewswire-USNewswire/ -- The rate of developing esophageal squamous cell carcinoma (ESCC) nearly doubles in those who both smoke and drink compared to those who only smoke or drink, according to new research published in The American Journal of Gastroenterology. Although multiple studies have identified risk factors for the development of ESCC, notably, exposure to alcohol and tobacco, this research is the first meta-analysis to look at the interaction...

2014-04-03 12:30:00

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth SummaryGBI Research has released the pharma report "Monoclonal...


Latest Esophageal cancer Reference Libraries

Gastroscopy
2013-03-04 10:13:56

The esophagogastroduodenoscopy is a medical diagnostic procedure used in internal medicine to view the upper part of the gastrointestinal tract. This non-invasive procedure is used for many complaints and requires little to no time for recovery from the procedure. Reasons for the Procedure Patients present to their physician with physical complaints. For example, a patient may come into the office and say they have been feeling tired and forgetful. Through many tests and evaluations,...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'